Wild ‐type LRRK2 as a new potential therapeutic target in idiopathic Parkinson's disease

Movement Disorders, EarlyView.

Source: Movement Disorders - November 19, 2018 Category: Neurology Authors: Hossein Sanjari Moghaddam, Mohammad Hadi Aarabi Tags: Hot Topics Source Type: research